Hicham Achebak1, Hervé Petetin2, Marcos Quijal-Zamorano3, Dene Bowdalo2, Carlos Pérez García-Pando4, Joan Ballester5. 1. Centre for Demographic Studies, Autonomous University of Barcelona, Barcelona, Spain; Climate and Health Program, Barcelona Institute for Global Health, Barcelona 08003, Spain. 2. Earth Sciences Department, Barcelona Supercomputing Center, Barcelona, Spain. 3. Climate and Health Program, Barcelona Institute for Global Health, Barcelona 08003, Spain. 4. Earth Sciences Department, Barcelona Supercomputing Center, Barcelona, Spain; ICREA, Barcelona, Spain. 5. Climate and Health Program, Barcelona Institute for Global Health, Barcelona 08003, Spain. Electronic address: joan.ballester@isglobal.org.
Lockdown measures reducing the transmission of COVID-19 have led to a temporal improvement in air quality worldwide. An assessment by Kai Chen and colleagues reported that a drop in air pollution in 367 Chinese cities was associated with 8911 prevented deaths because of a reduction in nitrogen dioxide (NO2; 95% CI 6950–10 866) and 3214 deaths from a reduction in PM2·5 (95% CI 2340–4087). However, the method for quantifying reductions in air pollution and attributable mortality is on the basis of several simplifications and assumptions that are likely to bias the estimates.First, air pollution reductions estimated with the difference-in-difference approach cannot be directly attributed to the lockdown because this method does not cancel out the effect of weather on air pollution. To show this point, we estimated the change in NO2 during lockdown in 48 Spanish provinces, from March 15 to April 23, 2020, by estimating business-as-usual concentrations with a meteorology normalisation technique based on machine learning, which shows the expected concentrations that would have occurred without lockdown. We then used exposure-response functions3, 4 to transform the daily observed and business-as-usual NO2 time series into daily NO2-attributable mortality time series, and the difference was compared with estimates obtained with the method in Chen and colleagues. Our unbiased method increased the reduction in NO2 by 11% on average and increased the reduction in attributable deaths by 6·5%. Depending on how anomalous the weather was during lockdown and the reference periods in each of the Chinese cities, the bias could be even larger.Second, the baseline mortality used by the authors to quantify the temporal reduction in number of deaths is from 2018. The choice of this particular year is unjustified, and the use of data from one year can lead to biases in the estimates, particularly for cause-specific mortality. In addition, Chen and colleagues used different sources of data for the calibration of historical exposure-response models and the estimations of the reduction in air pollution, which could lead to large biases because of inconsistent choice of air pollution stations.Finally, the authors state that “the COVID-19 outbreak led to improvements in air quality that brought health benefits in non-COVID-19deaths”. We would like to raise a note of caution, given that some of the prevented deaths might correspond to the oldest and frailest individuals whose death was brought forward by just a few days or weeks, or correspond to those individuals whose health is at risk given that air pollution in China has already exceeded concentrations before the crisis. In our opinion, improvements in air quality will result in a long-term benefit only if they are sustained in time.
Authors: Cong Liu; Renjie Chen; Francesco Sera; Ana M Vicedo-Cabrera; Yuming Guo; Shilu Tong; Micheline S Z S Coelho; Paulo H N Saldiva; Eric Lavigne; Patricia Matus; Nicolas Valdes Ortega; Samuel Osorio Garcia; Mathilde Pascal; Massimo Stafoggia; Matteo Scortichini; Masahiro Hashizume; Yasushi Honda; Magali Hurtado-Díaz; Julio Cruz; Baltazar Nunes; João P Teixeira; Ho Kim; Aurelio Tobias; Carmen Íñiguez; Bertil Forsberg; Christofer Åström; Martina S Ragettli; Yue-Leon Guo; Bing-Yu Chen; Michelle L Bell; Caradee Y Wright; Noah Scovronick; Rebecca M Garland; Ai Milojevic; Jan Kyselý; Aleš Urban; Hans Orru; Ene Indermitte; Jouni J K Jaakkola; Niilo R I Ryti; Klea Katsouyanni; Antonis Analitis; Antonella Zanobetti; Joel Schwartz; Jianmin Chen; Tangchun Wu; Aaron Cohen; Antonio Gasparrini; Haidong Kan Journal: N Engl J Med Date: 2019-08-22 Impact factor: 91.245
Authors: Ana M Vicedo-Cabrera; Francesco Sera; Cong Liu; Ben Armstrong; Ai Milojevic; Yuming Guo; Shilu Tong; Eric Lavigne; Jan Kyselý; Aleš Urban; Hans Orru; Ene Indermitte; Mathilde Pascal; Veronika Huber; Alexandra Schneider; Klea Katsouyanni; Evangelia Samoli; Massimo Stafoggia; Matteo Scortichini; Masahiro Hashizume; Yasushi Honda; Chris Fook Sheng Ng; Magali Hurtado-Diaz; Julio Cruz; Susana Silva; Joana Madureira; Noah Scovronick; Rebecca M Garland; Ho Kim; Aurelio Tobias; Carmen Íñiguez; Bertil Forsberg; Christofer Åström; Martina S Ragettli; Martin Röösli; Yue-Liang Leon Guo; Bing-Yu Chen; Antonella Zanobetti; Joel Schwartz; Michelle L Bell; Haidong Kan; Antonio Gasparrini Journal: BMJ Date: 2020-02-10
Authors: Carlos Sanchez-Piedra; Copytzy Cruz-Cruz; Ana-Estela Gamiño-Arroyo; Francisco-Javier Prado-Galbarro Journal: Air Qual Atmos Health Date: 2021-07-26 Impact factor: 3.763